GlassScriptPhysician profile
Ana Kaye Wilson
NPI 1154681138
$834.85
in general payments reported to CMS, 2019-2025
19 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.24 · 2020: $150 · 2022: $265 · 2023: $95.26 · 2024: $126 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $149.57 | 2020 | |
| Ethicon US, LLC | $115.77 | 2022-2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| Takeda Pharmaceuticals U.S.A., INC. | $68.04 | 2022-2024 | Gattex |
| Merck Sharp & Dohme LLC | $67.65 | 2022 | |
| Medtronic, INC. | $65.00 | 2023-2024 | Ligasure, Dextile |
| W. L. Gore & Associates, INC. | $49.11 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Davol INC. | $43.88 | 2025 | Phasix Mesh |
| Stryker Corporation | $40.33 | 2023-2024 | Spy-Phi System, Eikon Lt Adapt Smoke Evacuation, Eikon |
| Harmony Biosciences LLC | $31.11 | 2022 | |
| Mesh Suture INC | $30.15 | 2025 | |
| Dendreon Pharmaceuticals LLC | $26.24 | 2019 | |
| Innocoll Pharmaceuticals Limited | $25.11 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $24.06 | 2022 | |
| Leica Microsystems INC. | $20.42 | 2022 | |
| Teleflex LLC | $17.00 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $16.79 | 2022 | |
| Sanara Medtech INC. | $16.59 | 2023 | Celleraterx |
| Bard Peripheral Vascular, INC. | $14.15 | 2022 | |
| Currax Pharmaceuticals LLC | $13.88 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.